About Lygos
Lygos is a company based in Emeryville (United States) founded in 2010 by Eric Steen. It operates as a B2B2C. Lygos has raised $51.77 million across 24 funding rounds from investors including United States Department of Agriculture, Flexible Solutions and DOE. Lygos has completed 1 acquisition, including Librede. Lygos offers products and services including Soltellus TM, Agronomy Solutions, Home Care Solutions, Hygiene Solutions, and Personal Care Solutions. Lygos operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Evonik and Vividion Therapeutics, among others.
- Headquarter Emeryville, United States
- Founders Eric Steen
-
Sectors
Chemicals & MaterialsHealthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Lygos, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$51.77 M (USD)
in 24 rounds
-
Latest Funding Round
-
Investors
United States Department of Agriculture
& 16 more
-
Employee Count
Employee Count
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Lygos
Lygos offers a comprehensive portfolio of products and services, including Soltellus TM, Agronomy Solutions, Home Care Solutions, Hygiene Solutions, and Personal Care Solutions. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Specialty chemicals are developed for various industrial applications.
Solutions are provided to increase crop yields effectively.
Products are designed to remove soil and stains.
Polymers are created for high performance and sustainability.
Formulations are improved for haircare and skincare products.
Chemicals are used to prevent scale and corrosion.
Unlock access to complete
Unlock access to complete
Funding Insights of Lygos
Lygos has successfully raised a total of $51.77M across 24 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 24
- Last Round Last Round
-
First Round
First Round
(01 Jun 2011)
- Investors Count 17
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2021 | Amount | Series B - Lygos | Valuation | Flexible Solutions , NanoChem Solutions |
|
| Jul, 2019 | Amount | Grant - Lygos | Valuation |
investors |
|
| Apr, 2019 | Amount | Series B - Lygos | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Lygos
Lygos has secured backing from 17 investors, including institutional and venture fund investors. Prominent investors backing the company include United States Department of Agriculture, Flexible Solutions and DOE. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment in early-stage companies across AI, biotech, and cleantech sectors with access to global resources.
|
Founded Year | Domain | Location | |
|
Seed and early-stage venture capital firm focusing on investments in technology and fintech companies
|
Founded Year | Domain | Location | |
|
US focused seed and early-stage VC firm
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Lygos
Lygos has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Librede. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Yeast is engineered via synthetic biology for cannabinoid compound production.
|
2009 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Lygos
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Lygos Comparisons
Competitors of Lygos
Lygos operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Evonik and Vividion Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Green specialty chemicals are developed and supplied for multiple industries.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
RNA-editing technologies are provided for precision medicine applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Lygos
Frequently Asked Questions about Lygos
When was Lygos founded?
Lygos was founded in 2010 and raised its 1st funding round 1 year after it was founded.
Where is Lygos located?
Lygos is headquartered in Emeryville, United States. It is registered at Emeryville, California, United States.
Who is the current CEO of Lygos?
Eric Steen is the current CEO of Lygos. They have also founded this company.
Is Lygos a funded company?
Lygos is a funded company, having raised a total of $51.77M across 24 funding rounds to date. The company's 1st funding round was a Series B of $10.9M, raised on Jun 01, 2011.
What does Lygos do?
Specialty chemicals are produced by Lygos to enhance performance across multiple sectors including agronomy, home care, hygiene, personal care, and water treatment. Solutions are designed to improve crop yields, fight stains, balance sustainability with performance, enhance personal care formulations, and prevent corrosion in water systems. Practical innovations are delivered through material science and chemistry expertise, ensuring sustainable value at scale for customers without compromising on quality.
Who are the top competitors of Lygos?
Lygos's top competitors include Sutro Biopharma, Avidity Biosciences and Antheia.
What products or services does Lygos offer?
Lygos offers Soltellus TM, Agronomy Solutions, Home Care Solutions, Hygiene Solutions, and 2 more products and services.
How many acquisitions has Lygos made?
Lygos has made 1 acquisition, including Librede.
Who are Lygos's investors?
Lygos has 17 investors. Key investors include United States Department of Agriculture, Flexible Solutions, DOE, NanoChem Solutions, and LG Technology Ventures.